About Us

Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.

Press Releases

Feb 18, 2020

Muscular Dystrophy Association Rolls Out 38th Annual MDA Shamrocks Campaign with Retailers Nationwide

More than 20,000 retailers support fundraising campaign to transform the lives of people living with muscular dystrophy, ALS and related neuromuscular diseases throughout February and March
Jan 28, 2020

Muscular Dystrophy Association Announces 2020-2021 National Ambassador Ethan LyBrand from Alabama

Ethan's goals are to find a cure for all types of muscular dystrophy, help people get the healthcare they need when they need it and make airplanes more accessible for wheelchairs
Jan 13, 2020

MDA Awards Venture Philanthropy Funding of More Than $1M to AavantiBio to Develop Gene-Targeting Therapy for Friedreich's Ataxia
Dec 19, 2019

The Muscular Dystrophy Association Names Steven J. Farella as Chairman and Dr. Donald S. Wood as Vice Chairman of the Board

MDA is focused on driving innovations in research and care for people living with neuromuscular diseases.
Dec 13, 2019

MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping

Second approved exon-skipping therapy for Duchenne muscular dystrophy
Dec 9, 2019

Muscular Dystrophy Association Names Sharon Hesterlee, Ph.D., Executive Vice President, Chief Research Officer

An experienced drug development executive focused on neuromuscular disease, neuroscientist Dr. Hesterlee brings a unique background in the pharma, biotech and nonprofit sectors